IL17A and atherosclerosis: Chronic inflammation mediated by the Th17/IL-23/IL-17 axis promotes endothelial dysfunction and accelerates atherosclerosis through elevated levels of TNF-α, IL-17, and IL-6, which enhance vascular endothelial activation and plaque instability (32).